You just read:

Interpace Diagnostics Enters into Collaborative Agreement with Viatar CTC Solutions to Detect and Characterize Early Cancer in Liquid Biopsies

News provided by

Interpace Diagnostics Group, Inc.

21 Feb, 2017, 08:00 ET